Clinical Trials Sponsored by Pharos Life Corporation

Total 500 results

Life Technologies Corporation

Completed

Clinical Protocol SeCore, uTYPE and 3500 Dx System

Human Leukocyte Antigens (HLA)
Dr Cipto Mangunkusumo General Hospital
Astellas Pharma Indonesia Inc.; Pharos Life Corporation

Unknown

The Efficacy of Solifenacin Succinate as Adjuvant Therapy for Urinary Tract Infection in Females

Urinary Tract Infection

Indonesia
Research in Real-Life Ltd
Orion Corporation, Orion Pharma

Completed

Real Life Effectiveness of Easyhaler (Orion)

Asthma
RepliCel Life Sciences, Inc.
Syreon Corporation

Withdrawn

Long-Term Follow-up of the Safety and Efficacy of RCT-01 in Men and Women With Unilateral, Chronic Achilles Tendinosis (ReaCT-X)

Tendinopathy | Tendinosis

Canada
Sichuan Huiyang Life Science and Technology Corporation

Active, not recruiting

rSIFN-co Among Healthy Subjects and Subjects With Mild or Asymptomatic COVID-19

COVID-19 | SARS-CoV-2 Infection

Philippines
Sichuan Huiyang Life Science and Technology Corporation

Completed

A Study of rSIFN-co in Subjects With Advanced Solid Tumors (rSIFN-01)

Melanoma | Carcinoma, Renal Cell | Carcinoma, Non-Small-Cell Lung | Carcinoma, Hepatocellular | Colon Cancer

Singapore
Tree of Life Pharma Ltd.

Completed

Investigation of the Safety and Efficacy of Pocket-X Gel

Periodontal Pocket

Israel
Lite-On Technology Corporation H.S.P.B

Unknown

Performance Evaluation of In-Vitro Diagnostic Device

Blood Routine Examination

Taiwan
Jamp Pharma Corporation

Recruiting

The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Adalimumab (AVT-02) Across Multiple Indications. (EASE PAIN)

Rheumatoid Arthritis | Plaque Psoriasis | Crohn Disease | Ulcerative Colitis | Hidradenitis Suppurativa | Psoriatic Arthritis | Ankylosing Spondylitis

Canada
Zosano Pharma Corporation

Completed

Double-Blind Comparison of the Efficacy and Safety of C213 to Placebo for the Acute Treatment of Cluster Headaches

Cluster Headache

United States
Zosano Pharma Corporation

Completed

A Study of M207 With Intranasal Zolmitriptan in Healthy Volunteers

Migraine

United States
Zosano Pharma Corporation

Completed

Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine (Zotrip)

Acute Migraine

United States
Matrizyme Pharma Corporation

Completed

Total Occlusion Study in Coronary Arteries - 5 (TOSCA-5)

Chronic Coronary Total Occlusions

Canada, Israel, Netherlands
Zosano Pharma Corporation

Completed

A Four-way Crossover Study of 3 Formulations of M207 With Intranasal Zolmitriptan in Healthy Volunteers

Migraine

United States
Zosano Pharma Corporation

Completed

Study of PK, Safety, and Tolerability of 2 Lots of M207 & Intranasal Zolmitriptan in Healthy Volunteers

Migraine

United States
Zosano Pharma Corporation

Completed

A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine (ADAM)

Migraine

United States
Zosano Pharma Corporation

Completed

Dose Ranging Study - Macroflux Parathyroid Hormone (PTH) in Postmenopausal Women With Osteoporosis

Osteoporosis
Zosano Pharma Corporation

Completed

A Study to Determine the Patient Preference Between Zosano Pharma Parathyroid Hormone (ZP-PTH) Patch and Forteo Pen

Postmenopausal Osteoporosis

United States
Zosano Pharma Corporation

Completed

Safety and Efficacy of ZP-Glucagon to Injectable Glucagon for Hypoglycemia

Hypoglycemia

Australia
Breath of Life International Pharma Ltd

Withdrawn

A Study to Evaluate the Safety and Efficacy of BOL-DP-o-08 in Patients With Endometriosis Syndrome.

Endometriosis
Breath of Life International Pharma Ltd

Completed

A Phase I Open Label Study to Assess PK and Safety of Plant Cannabis Extract

Healthy

Israel
Breath of Life International Pharma Ltd

Completed

BOL-DP-o-04 in Patients With Low Back Pain and Sciatica

Low Back Pain | Sciatica

Israel
Breath of Life International Pharma Ltd

Withdrawn

BOL-DP-o-05 as an Add-On Treatment of Subjects With Newly Diagnosed Type 1 Diabetes Mellitus

Type1 Diabetes Mellitus
Breath of Life International Pharma Ltd

Terminated

Phase 2a Study Examining the Safety and Efficacy of BOL-DP-o-04 for Treating Diabetic Neuropathy

Diabetic Neuropathy

Israel
Mitsubishi Tanabe Pharma Corporation
Kureha Corporation

Completed

A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease (EPPIC-1)

Chronic Kidney Disease

United States, France, Italy, Ukraine, Argentina, Mexico, Poland, Canada, Brazil, Russian Federation, Czechia, Puerto Rico
Mitsubishi Tanabe Pharma Corporation
Kureha Corporation

Completed

A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease Including Assessment of Quality of Life (EPPIC-2)

Chronic Kidney Disease

United States, Poland, Ukraine, Spain, Argentina, Mexico, Canada, Brazil, Russian Federation, Puerto Rico, Germany, Czechia
Sichuan Huiyang Life Science and Technology Corporation
Medelis Inc.

Active, not recruiting

Study of rSIFN-co for Patients With Advanced Solid Tumors

Malignancies Including Melanoma, Kidney, Lung, Colorectal, Prostate, Neuroendocrine Tumor

United States
RepliCel Life Sciences, Inc.
Syreon Corporation; Innovacell Biotechnologie AG

Terminated

Safety and Efficacy of RCT-01 in Men and Women With Unilateral, Chronic Achilles Tendinosis (ReaCT)

Tendinopathy | Tendinosis

Canada
PDC*line Pharma SAS

Active, not recruiting

Safety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLC

Non Small Cell Lung Cancer

Belgium, France, Netherlands, Germany, Poland
Lallemand Pharma AG
Sprim Advanced Life Sciences

Completed

Advanced Immunological Approach in COPD Exacerbation (AIACE)

Chronic Obstructive Pulmonary Disease (COPD)

Italy
Mitsubishi Tanabe Pharma Corporation

Recruiting

An Exploratory Study of MT-2990 in Patients With AAV

Antineutrophil Cytoplasmic Antibody (ANCA) -Associated Vasculitis (AAV)

Japan
Orion Corporation, Orion Pharma

Completed

Safety and Pharmacokinetics of ODM-209 (STESIDES)

Advanced Breast Cancer | Metastatic Breast Cancer | Castration-resistant Prostate Cancer | Prostate Cancer Metastatic

Finland, France, Denmark
Mitsubishi Tanabe Pharma Corporation

Completed

Comparative Bioavailability Study of Oral Edaravone Administered Orally and Via a Nasogastric Tube

Healthy Adult Subjects

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety Study to Evaluate MT-6548 in Peritoneal Dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan

Anemia; Peritoneal Dialysis Dependent Chronic Kidney Disease

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Currently Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan

Anemia; Hemodialysis Dependent Chronic Kidney Disease

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Effects of Iron Supplements on the Pharmacokinetics of MT-6548

Healthy

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Extension Study Following the Studies MT-1186-A03 or A04 to Evaluate the Safety of Oral Edaravone in Subjects With ALS

ALS

Japan
Orion Corporation, Orion Pharma

Completed

Use of Buventol Easyhaler and Bufomix Easyhaler in Methacoline Challenge Testing (EASYRELIEF)

Asthma

Finland
Orion Corporation, Orion Pharma

Completed

Comparison of Tiotropium Absorption From Tiotropium Easyhaler and Spiriva HandiHaler (TEMPO)

Healthy Volunteers

Finland
Orion Corporation, Orion Pharma

Completed

Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS (REFALS)

Amyotrophic Lateral Sclerosis

Canada, United States, Australia, Austria, United Kingdom, Germany, Finland, Spain, France, Italy, Sweden, Netherlands, Belgium, Ireland
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety of Teneligliptin in Chinese Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

China
Orion Corporation, Orion Pharma

Completed

Absorption of Indacaterol and Glycopyrronium From Ultibro Breezhaler (FINDA)

Healthy Volunteers

Finland
Orion Corporation, Orion Pharma

Terminated

Switch of Budesonide-formoterol Dry Powder Inhalers at Pharmacy in Norway (BufoSwitch)

Asthma | COPD

Norway
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety of Canagliflozin (TA-7284) in Patients With Diabetic Nephropathy

Diabetic Nephropathy

Japan
Asahi Kasei Pharma Corporation

Completed

Clinical Study of AK1820 (Isavuconazonium Sulfate) for the Treatment of Deep Mycosis

Deep Mycosis

Japan
Orion Corporation, Orion Pharma

Completed

Blood-Brain Barrier Penetration of Therapeutic Agents in Human (BRIAN)

CNS Disease

Finland
Mitsubishi Tanabe Pharma Corporation

Completed

Safety and Efficacy of MP-214 in Patients With Schizophrenia

Schizophrenia

Taiwan, Korea, Republic of, Japan
Orion Corporation, Orion Pharma

Completed

Inspiratory Flow Parameters With Placebo Easyhaler and Placebo HandiHaler (TIOPIF)

Healthy Volunteer | COPD

Estonia
Mitsubishi Tanabe Pharma Corporation

Completed

Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With GLP-1 Analogue in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Clinical Study of TA-650 in Patients With Refractory Kawasaki Disease

Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin

Japan

Clinical Trials Sponsored by Pharos Life Corporation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Vietnam

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations